Search

everythinglearnresearchcommunity

for

Search:↓

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Some skin medication can rarely cause or worsen mental health issues; knowing this is important because mental health problems are increasing worldwide.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Fire Needle Therapy may help bring back skin color in vitiligo by affecting cell growth signals.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Stress might contribute to hair loss in alopecia areata.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

New understanding and treatments for hair loss are improving, but more research is needed.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

Two Sikh brothers developed permanent hair loss from wearing turbans tightly, a condition that became apparent after they moved to Austria.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

A woman's excessive hair growth around a leg ulcer was linked to a treatment with Prostaglandin E1 ointment.

Some alternative therapies for vitiligo show promise but need more research.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Iron deficiency might contribute to hair loss in women.

New cytokine-targeted therapies show promise for treating alopecia areata.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.